Antitumor Effects of JAK3 Inhibitor on the Model of Transplantable Lewis Lung Carcinoma and Mechanisms of Their Development


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Mice with Lewis lung carcinoma were used to study the antitumor and antimetastatic effects of JAK3 inhibitor. The study revealed no effect of JAK3 inhibitor on the growth of primary tumor node, but found a pronounced inhibition of hematogenous spread of the pathologic process into the lungs. In vitro blockade of JAK3 in cultured Lewis lung carcinoma produced no effect on the count of the stem tumor cells and stimulated functions of committed elements. In addition, blockade of JAK3 significantly elevated maturation index of the tumor tissue.

Sobre autores

G. Zyuz’kov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; Laboratory of Physical Processes Modeling in Biology and Medicine, National Research Tomsk State University

Autor responsável pela correspondência
Email: zgn@pharm.tsu.ru
Rússia, Tomsk; Tomsk

E. Amosova

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

A. Chaikovskii

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

L. Miroshnichenko

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

E. Udut

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

O. Rybalkina

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

V. Zhdanov

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

V. Udut

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; Laboratory of Physical Processes Modeling in Biology and Medicine, National Research Tomsk State University

Email: zgn@pharm.tsu.ru
Rússia, Tomsk; Tomsk

A. Dygai

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk

E. Zueva

E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Rússia, Tomsk


Declaração de direitos autorais © Springer Science+Business Media New York, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies